Biotech Foundations: Biotech VC Larry Bock Uses Start-up Spirit in Science Fest Oct. 13, 2010 By Trista Morrison
Synosia Therapeutics Nabs Potential $725M Pact with UCB Oct. 13, 2010 By Nuala Moran LONDON – Synosia Therapeutics sealed a $725 million pact on its two lead drugs for treating Parkinson's disease with UCB Pharma, and announced the closing of a third round funding of $30 million. (BioWorld International)Read More
RSS